Utama › Gangguan Darah › Texas › Houston
Kajian klinikal Gangguan Darah di Houston, TX
9 kajian untuk Gangguan Darah sedang mencari peserta di lokasi dalam dan sekitar Houston (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
Mengambil pesertaFasa 3
- Texas Childrens Cancer and Hematology Center, Houston
- U of TX Health Science Ct, Houston
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Mengambil pesertaFasa 3
- Quetzal Site 6, Houston
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Mengambil pesertaFasa 3
- Baylor College of Medicine, Houston
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Mengambil pesertaFasa 2
- The University of Texas MD Anderson Cancer Center, Houston
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Mengambil pesertaFasa 3
- Baylor College of Medicine, Houston
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Mengambil pesertaKajian pemerhatian
- Gulf States Hemophilia and Thrombophilia Center, Houston
- Texas Children's Hemophilia & Thrombosis Center/Baylor College of Medicine, Houston
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Mengambil pesertaFasa 2/3
- MD Anderson Cancer Center, Houston
Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs
Mengambil pesertaFasa 1
- The University of Texas MD Anderson Cancer Center, Houston
Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
Mengambil pesertaFasa 1
- MD Anderson Cancer Center, Houston
Kajian Gangguan Darah di bandar lain
- Boston, MA10 kajian
- Atlanta, GA10 kajian
- Los Angeles, CA9 kajian
- The Bronx, NY8 kajian
- New York City, NY7 kajian
- Nashville, TN7 kajian
- Mountain View, CA6 kajian
- Durham, NC5 kajian
- Portland, OR5 kajian
- Washington, DC5 kajian
- Seattle, WA5 kajian
- Greenville, NC5 kajian
Kajian lain di Houston
- Kanser Paru-paru Bukan Sel Kecil145 kajian
- Kanser Payudara126 kajian
- Kanser (semua jenis)121 kajian
- Kanser Metastatik104 kajian
- Kanser Kolorektal102 kajian
- Kanser Ovari89 kajian
- Leukemia Mieloid Akut85 kajian
- Kanser Paru-paru78 kajian
- Kanser Prostat76 kajian
- Kanser Endometrium68 kajian
- Kanser Pankreas61 kajian
- Melanoma59 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.